This announcement is a separate document:
圣湘生物科技股份有限公司2024年第一季度报告
Shengxiang Biotechnology Co., Ltd. 2024 First Quarter Report
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Symbol Mini Chart Price
Log In for the Full List
Latest
00:53
Another executive order is being challenged in court; Trump's efforts to simplify the federal employee termination process are facing legal challenges.
00:46
The Prime Minister of Greenland seeks to have direct dialogue with Trump, reiterating that the island will not be sold.
00:32
The USA Treasury auctioned three-month treasury bills with a winning rate of 4.215% (previously 4.225%), with a bid-to-cover ratio of 2.80 (previously 3.09). The auction for six-month treasury bills had a winning rate of 4.165% (previously 4.180%), with a bid-to-cover ratio of 3.04 (previously 2.81).
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.